Clinical trial reportAmerican journal of hematologyPublished
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study
Regional connection
Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source
- Institution
- University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- American journal of hematology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Lymphoma; Neoplasm Recurrence, Local; Organic Chemicals; Thalidomide; Sirolimus; Antineoplastic Combined Chemotherapy Protocols; Protein Kinase Inhibitors; Treatment Outcome; Adult; Aged; Aged, 80 and over
- PubMed ID
- 36810799
- Added to directory
- Source checked